9 stories found
DocuSign reports that Identity and Access Management (IAM) now accounts for 15% of its Annual Recurring Revenue (ARR), raising questions about whether this platform mix can drive total ARR growth beyond single digits.
DocuSign (DOCU) reported Q4 profits that surpassed expectations with an EPS of $1.01, while Piper Sandler maintained a 'Neutral' rating on the stock.
RBC has expressed caution regarding DocuSign (DOCU) following the release of the company's fourth-quarter financial results.
UBS analysts have reduced their price target for DocuSign (DOCU) stock, with reasons for the adjustment provided.
DocuSign continues to be the subject of takeover speculation as it deepens its focus on intelligent agreements. The company's strategic shift into AI-powered solutions likely makes it an attractive target for potential acquirers.
Analysts are offering their insights and perspectives on the performance and outlook of technology companies including Micron, DocuSign, and IBM, with specific advice on whether to 'buy the dip' on Micron.
An analysis explores the factors that make Docusign (DOCU) an attractive company.